Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, School of Life Sciences and Technology, Shanghai Fourth People's Hospital, Tongji University, Shanghai 200434, China; Institute of Biophysics, Chinese Academy of Science, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, School of Life Sciences and Technology, Shanghai Fourth People's Hospital, Tongji University, Shanghai 200434, China.
Phytomedicine. 2023 May;113:154743. doi: 10.1016/j.phymed.2023.154743. Epub 2023 Mar 5.
Pyroptosis is an inflammatory form of cell death that has been implicated in various infectious and non-infectious diseases. Gasdermin family proteins are the key executors of pyroptotic cell death, thus they are considered as novel therapeutic targets for inflammatory diseases. However, only limited gasdermin specific inhibitors have been identified to date. Traditional Chinese medicines have been applied in clinic for centuries and exhibit potential in anti-inflammation and anti-pyroptosis. We attempted to find candidate Chinese botanical drugs which specifically target gasdermin D (GSDMD) and inhibit pyroptosis.
In this study, we performed high-throughput screening using a botanical drug library to identify pyroptosis specific inhibitors. The assay was based on a cell pyroptosis model induced by lipopolysaccharides (LPS) and nigericin. Cell pyroptosis levels were then evaluated by cell cytotoxicity assay, propidium iodide (PI) staining and immunoblotting. We then overexpressed GSDMD-N in cell lines to investigate the direct inhibitory effect of the drug to GSDMD-N oligomerization. Mass spectrometry studies were applied to identify the active components of the botanical drug. Finally, a mouse model of sepsis and a mouse model of diabetic myocardial infarction were constructed to verify the protective effect of the drug in disease models of inflammation.
High-throughput screening identified Danhong injection (DHI) as a pyroptosis inhibitor. DHI remarkably inhibited pyroptotic cell death in a murine macrophage cell line and bone marrow-derived macrophages. Molecular assays demonstrated the direct blockade of GSDMD-N oligomerization and pore formation by DHI. Mass spectrometry studies identified the major active components of DHI, and further activity assays revealed salvianolic acid E (SAE) as the most potent molecule among these components, and SAE has a strong binding affinity to mouse GSDMD Cys192. We further demonstrated the protective effects of DHI in mouse sepsis and mouse myocardial infarction with type 2 diabetes.
These findings provide new insights for drug development from Chinese herbal medicine like DHI against diabetic myocardial injury and sepsis through blocking GSDMD-mediated macrophage pyroptosis.
细胞焦亡是一种炎症形式的细胞死亡,与多种感染性和非感染性疾病有关。Gasdermin 家族蛋白是细胞焦亡的关键执行者,因此被认为是炎症性疾病的新型治疗靶点。然而,迄今为止仅鉴定出有限的 Gasdermin 特异性抑制剂。传统中药已在临床上应用了几个世纪,并在抗炎和抗细胞焦亡方面显示出潜力。我们试图寻找专门针对 Gasdermin D (GSDMD) 并抑制细胞焦亡的候选中药植物药。
在这项研究中,我们使用植物药物库进行高通量筛选,以鉴定细胞焦亡特异性抑制剂。该测定基于脂多糖 (LPS) 和 Nigericin 诱导的细胞焦亡模型。然后通过细胞毒性测定、碘化丙啶 (PI) 染色和免疫印迹评估细胞焦亡水平。我们随后在细胞系中过表达 GSDMD-N,以研究药物对 GSDMD-N 寡聚的直接抑制作用。应用质谱研究鉴定植物药物的活性成分。最后,构建了脓毒症小鼠模型和糖尿病心肌梗死小鼠模型,以验证药物在炎症疾病模型中的保护作用。
高通量筛选鉴定丹红注射液 (DHI) 为细胞焦亡抑制剂。DHI 显著抑制了小鼠巨噬细胞系和骨髓来源的巨噬细胞中的细胞焦亡死亡。分子测定表明 DHI 直接阻断 GSDMD-N 寡聚化和孔形成。质谱研究鉴定了 DHI 的主要活性成分,进一步的活性测定表明,丹酚酸 E (SAE) 是这些成分中最有效的分子,并且 SAE 与小鼠 GSDMD Cys192 具有很强的结合亲和力。我们进一步证明了 DHI 在脓毒症小鼠和 2 型糖尿病心肌梗死小鼠中的保护作用。
这些发现为开发中药(如 DHI)治疗糖尿病心肌损伤和脓毒症提供了新的思路,通过阻断 GSDMD 介导的巨噬细胞焦亡。